MIC Capital Management UK LLP

Position in RVMD — Revolution Medicines, Inc.

CIK 1889830 LONDON, X0

Position in RVMD

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$99,582,956

+$22,197,922 QoQ

Shares Held

531,733

-33.2% QoQ

Ownership

0.248%

of shares outstanding

% of Portfolio

25.25%

of 13F equity value

Holder Rank

#62

of 687 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MIC Capital Management UK LLP holds $143,782,490 across 4 Biotechnology names. RVMD ranks #1 (69.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc. This page	531,733	$99,582,956
2	RXRX	Recursion Pharmaceuticals, Inc.	9,644,033	$35,393,601
3	NMRA	Neumora Therapeutics, Inc.	4,460,700	$7,583,190
4	LYEL	Lyell Immunopharma, Inc.	87,028	$1,222,743

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$99,582,956	531,733	-33.2%	Shares	Sole	2026-08-10
2026-03-31	$77,385,034	795,733	+56.5%	Shares	Sole	2026-05-13
2025-12-31	$40,507,520	508,569	0.0%	Shares	Sole	2026-02-17
2025-09-30	$23,750,172	508,569	0.0%	Shares	Sole	2025-11-14
2025-06-30	$18,710,253	508,569	0.0%	Shares	Sole	2025-08-14
2025-03-31	$17,982,999	508,569	0.0%	Shares	Sole	2025-05-15
2024-12-31	$22,244,808	508,569	0.0%	Shares	Sole	2025-02-14
2024-09-30	$23,063,604	508,569	0.0%	Shares	Sole	2024-11-14
2024-06-30	$19,737,562	508,569	0.0%	Shares	Sole	2024-08-14
2024-03-31	$16,391,178	508,569	0.0%	Shares	Sole	2024-05-15
2023-12-31	$14,585,758	508,569	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.